Patients with non-ST-segment elevation acute coronary syndrome had a significantly higher rate of 2- or 3-vessel disease (25.3% vs 19.6%) and were more frequently recommended CABG surgery compared to patients with STEMI.
Observational (n=252)
No
What are the differences in clinical, demographic, and angiographic characteristics between patients presenting with STEMI versus NSTE-ACS?
NSTE-ACS patients present with more complex multivessel disease and comorbidities compared to STEMI patients, who present with lower ejection fractions.
Absolute Event Rate: 25.3% vs 19.6%
p-value: p=<0.001
Objective: Acute coronary syndromes are a group of life-threatening conditions frequently encountered in emergency departments. However, the clinical and demographic characteristics of these syndromes according to their subtypes have not been thoroughly investigated. This study examined possible differences in the clinical and demographic characteristics of ACS subtypes.Material and Method: The study included 252 consecutive patients presenting with ACS (NSTE-ACS and STEMI). Study data were obtained using a pre-prepared online case report form. The data were statistically evaluated in terms of clinical and demographic characteristics according to ACS type.Results: A total of 252 ACS patients (177 men and 75 women with a mean age of 63.2 ± 12.2 years) were included in the study. The prevalence of hypertension, hyperlipidaemia, diabetes and active smoking was 47.2%, 33.3%, 33.7% and 41.3%, respectively. At the time of admission, 40.5% of cases were diagnosed as STEMI and 59.5% as NSTE-ACS. The most common method of admission was by private vehicle (57.1%), while 31% were admitted by ambulance. Forty-five point two per cent of patients had a family history of coronary artery disease, and 23.8 per cent had undergone a cardiology clinic check-up in the past three months. A history of coronary artery bypass grafting (10.7%), stenting (34.1%) and pacemaker implantation (3.2%) was identified. Angiography was performed on 225 patients prior to discharge. Stenting was planned for 76.2% of patients, coronary artery bypass grafting (CABG) for 3.2%, and medical treatment for 11.5%. In the NSTE-ACS group, the rates of two- to three-vessel disease and CABG/medical treatment were significantly higher than in the STEMI group (p 0.001). Male gender predominated in both groups.Conclusion: Our study found that there were some differences in clinical characteristics between STEMI and NSTEMI cases, and our results were consistent with those reported in the literature.
Işık et al. (Tue,) conducted a observational in Acute Coronary Syndrome (n=252). NSTE-ACS vs. STEMI was evaluated on Rate of 2 or 3 vessel disease (p=<0.001). Patients with non-ST-segment elevation acute coronary syndrome had a significantly higher rate of 2- or 3-vessel disease (25.3% vs 19.6%) and were more frequently recommended CABG surgery compared to patients with STEMI.